SCHEMBL6558754

SCHEMBL6558754

CCCCCCC(CCCC)CC(C(=O)O)C(O)(CC(CCCC)CCCCCC)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.56
BLM P54132 1/20 0.56
HSPE1 P61604 1/20 0.56
MEN1 O00255 1/20 0.51
HPGD P15428 1/20 0.51
RECQL P46063 1/20 0.51
KMT2A Q03164 1/20 0.51
HSD17B10 Q99714 1/20 0.51
GRIK1 P39086 2/20 0.42
GRIK2 Q13002 2/20 0.42
GPR84 Q9NQS5 6/20 0.41
FFAR1 O14842 1/20 0.41
MAPT P10636 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
SLC1A2 P43004 2/20 0.40
SLC1A1 P43005 2/20 0.40
ACE2 Q9BYF1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15361848 0.98 HSPD1 (0.57) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL3394206 0.87 HSPD1 (0.47) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL25188201 0.78 HSPD1 (0.42) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL25204977 0.77 HSPD1 (0.41) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL28243973 0.77 HSPD1 (0.64) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL19945984 0.76 HSPD1 (0.43) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL14672441 0.73 HSPD1 (0.73) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL429973 0.73 HSPD1 (0.73) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL8416049 0.73 HSPD1 (0.73) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL27449447 0.73 HSPD1 (0.73) HSPD1BLMHSPE1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490018-A2 SUNSCREEN COMPOSITIONS AND METHODS AND MATERIALS FOR PRODUCING THE SAME The C.P. Hall Company (US) 2004-12-29 EP disclosed
US-6770270-B2 CONTROLLING POLARITY OF SOLVENT SYSTEM TO CONTROL RATE OF PHOTODECAY OF FILTER SYSTEM; COSMETICS THE C.P. HALL COMPANY 2004-08-03 US disclosed
US-20030194384-A1 Methods of making and selling a sunscreen composition THE C.P. HALL COMPANY 2003-10-16 US disclosed
WO-2003075878-A2 METHODS OF MAKING AND SELLING A SUNSCREEN COMPOSITION THE C.P. HALL COMPANY (US) 2003-09-18 WO disclosed
WO-2003075877-A2 SUNSCREEN COMPOSITIONS AS WELL AS METHODS AND MATERIALS FOR PRODUCING THE SAME, WHEREIN THE PHOTODECAY RATE OF THE FILTER SYSTEM IS REDUCED BY CONTROLLING THE POLARITY OF THE SOLVENT SYSTEM THE C.P. HALL COMPANY (US) 2003-09-18 WO disclosed
US-6537529-B1 Controlling solvent polarity to control rate of filter system photodecay THE C.P. HALL COMPANY 2003-03-25 US disclosed
US-6485713-B1 CONTROLLING THE POLARITY OF A SOLVENT SYSTEM IN THE COMPOSITION TO CONTROL THE RATE OF PHOTODECAY OF A FILTER SYSTEM IN THE COMPOSITION THE C. P. HALL COMPANY 2002-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030194384-A1 Methods of making and selling a sunscreen composition LSS, SUN2, CUTA HSPD1 2117/4885BLM 1553/4885HSPE1 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.